Strategy Lead, Technology and Manufacturing , Shanghai Cellular Biopharmaceutical Group Ltd. (CBMG)
Dr. Robin Ng joined CBMG as Strategy Lead for Technology and Manufacturing in June 2018. Prior to joining CBMG, Dr. Ng holds a position as a Process Science Fellow for the Bioproduction Division of Thermo Fisher Scientific, where his team oversees the Cell Culture and Cell Therapy technical team in Asia Pacific. Prior to that, Dr. Ng is the Senior Bioengineer at Takeda (previously Shire Human Genetic Therapy) where he led the tech transfer of the first 2,000L disposable bioreactor system. Dr. Ng started his career as the Senior Scientist at Goodwin Biotechnology, where he led the Upstream Process Development lab. He got his Ph.D. degree in Chemical and Biomolecular Engineering from Ohio State and a M.Sc. degree in Technology Commercialization from D’Amore-McKim School of Business at Northeastern University. Robin received his B. Sc. In Chemical and Biomolecular Engineering at National Central University in Taiwan.